Qubit Pharmaceuticals
Developer of drugs for the treatment of cancer and inflammatory diseases. The company uses software and AI-enhanced medicinal chemistry to develop novel drug candidates in the areas of oncology, inflammation, and pandemics response. Founded in 2020, headquartered in Paris, France. The company has raised $24.6M in funding at the seed stage. The team comprises 60 (Jun 30, 2026) employees. Backed by investors including…
Funding snapshot
About
Developer of drugs for the treatment of cancer and inflammatory diseases. The company uses software and AI-enhanced medicinal chemistry to develop novel drug candidates in the areas of oncology, inflammation, and pandemics response. Founded in 2020, headquartered in Paris, France. The company has raised $24.6M in funding at the seed stage. The team comprises 60 (Jun 30, 2026) employees. Backed by investors including XAnge, Quantonation, Omnes Capital, EIT Health. The company operates in the Life Sciences Platforms and Tools sector with additional focus on Oncology and Quantum Computing. Its business model centers on Simulation. Founded in 2020, headquartered in Paris, France. The company has raised $24.6M at the Seed stage. Backed by investors including XAnge, Quantonation, Omnes Capital, EIT Health, EIC Fund.
Business model
Quantum Computing > Quantum Software > Development Platforms > Simulation,
Oncology > Drugs > Diversified,
Life Sciences Platforms and Tools > Research Services > Diversified
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.
Raising like Qubit Pharmaceuticals?
Analyze your pitch deck before your next raise.
Analyze My Deck →